Search

Filter:

Search Results

AbbVie is hit with 5 lawsuits citing the dangers of its 'low T' drug

with the magazine said most men don't need the drugs. The recent lawsuits, filed by either Simmons Browder ...

Singapore fling: AbbVie says a plant in Asia is just what it needs

forecasts AbbVie aims for FDA filing on first hep C drug in 2014's second quarter Humira sales, up 19%, ...

Allergan sales fueled by Botox, eye-care strength; Crohn's market to see 'modest' growth; Mallinckrodt eyes $2.3B in fiscal 2014 sales;

with a $285M IPO.  More > Buzz: Novartis mulls selling its vaccine unit as swap deal with Merck stalls.  Story > Study: Merck's and GSK's HPV vaccines don't encourage risky sex.  Piece ...

Sanofi bets on its 'high-potential' pipeline; Ipsen preps muscle-spasm drug for review;

tightening its supply chain, turns in a surprising financial report.  Item Vaccines News > GSK is refusing to write off its cancer vaccine despite last year's PhIII flop.  Article > Circassia to test U.K. ...

Biomet offers at least $56M to settle some metal hip lawsuits; Manufacturers to slash price of drug-eluting stents in India;

selling its vaccine unit as swap deal with Merck stalls.  Story > Study: Merck's and GSK's ...

Three more biotechs snag $196M in a huge week for IPOs

for Phase III this year with an FDA filing planned for 2016. With those three pricings in the books, ...

After tougher-than-expected 2013, Sanofi anticipates patent-cliff freedom

nonpharma businesses--vaccines, animal health, and consumer health--turned in a mixed performance, with the vaccines business flat, animal health down on increased competition, and consumer health up. Sanofi ...

With biotech stocks sizzling, drug developers are bringing home the bacon

season Agenus stock jumps on Phase II brain cancer vaccine data Idera's troubled TLR program ...

A judge said J&J wrongly eliminated thousands of key vaginal mesh docs

in other files that had been subsequently turned over to plaintiffs. Previously, Ethicon has acknowledged ...

AbbVie picks Singapore for a $320M production facility

file photo The maker of Humira, the best-selling drug in the world, said Wednesday that it will invest ...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • next ›
  • last »